INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-158649166 assay]( "Getting The Most Out Of Cell-Based Assays With The Optimal Read Function")
Getting The Most Out Of Cell-Based Assays With The Optimal Read FunctionGain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.
-
![IDBS Polar]( "Scientific Data Is Not AI‑Ready By Default")
Scientific Data Is Not AI‑Ready By DefaultConvert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
![Pills-GettyImages-2216055021]( "Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing")
Overcoming API Constraints And Tight Timelines With On-Demand ManufacturingUse innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.
-
![GettyImages-1214112149-lab-team-collaboration-research]( "Your Guide To Precise And Robust Separation Methods")
Your Guide To Precise And Robust Separation MethodsDiscover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
White Paper: Characterization Of Spray Dried Biologics5/7/2025
Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.
-
Assessing Viability And Real-Time Apoptosis/Necrosis3/17/2025
Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
Microglia: Where We Came From And Where We Are Now10/8/2024
Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.
-
The Analytical Advantage Across The Development Lifecycle5/7/2026
Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety9/16/2025
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
DRUG DEVELOPMENT SOLUTIONS
-
![iStock-1172202165-plan]( "Develop. De-risk. Deliver.")
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.
-
![leica-microsystems-dm6-b-hero]( "Intelligent Automation for Life Science and Clinical Applications")
Leica DM6 B Upright Microscope
Increase your work efficiency with the Leica DM4 B or Leica DM6 B upright digital research microscopes! Both are ideally suited to making your work life easier in biomedical research and clinical labs alike.
- Simplify your workflow with automated functions and easy-to-use software
- Easily capture publication-quality images by utilizing the 19-mm sCMOS camera imaging port
- Create fast overviews of your samples and identify the important details instantly with the LAS X Navigator Software
- Have great flexibility through the choice of accessories
-
![peptide-cdmo-GettyImages-185209542]( "Peptide CDMO Services")
Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
![data-clinicial-GettyImages-2185301670]( "Streamline Experiments From Design To Decide")
Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.
